SCOPUS 정보 검색 플랫폼

Volumn 89, Issue 3, 2000, Pages 615-618

A Phase II trial of bryostatin-1 for patients with metastatic renal cell carcinoma

(8) Pagliaro, Lance a Daliani, Danai a Amato, Robert a Tu, Shi Ming a Jones, Donnah a Smith, Terry a Logothetis, Christopher a Millikan, Randall a

a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER (United States)

Author keywords

Bryostatin; Clinical trial; Phase II; Renal cell carcinoma

Indexed keywords

ALCOHOL; BRYOSTATIN 1; MACROGOL; POLYSORBATE 80;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG MIXTURE; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; KIDNEY CARCINOMA; LYMPHOCYTOPENIA; MALE; METASTASIS; MYALGIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LACTONES; MACROLIDES; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 0034254971 PISSN: 0008543X EISSN: None Source Type: Journal
DOI: 10.1002/1097-0142(20000801)89:3<615::AID-CNCR17>3.0.CO;2-J Document Type: Article

Times cited : (41)

References (11)

1
- 0030931682
- Natural history and therapy of metastatic renal cell carcinoma: The role of interleukin-2
- (1997) Cancer , vol.7 , pp. 1198-1220
- Bukowski, R.M.¹

2
- 0020408957
- Isolation and structure of bryostatin-1
- (1982) J Am Chem Soc , vol.104 , pp. 6846-6848
- Pettit, G.R.¹ Herald, C.L.² Doubek, D.L.³ Herald, D.L.⁴

3
- 0010050058
- Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells
- (1987) Proc Natl Acad Sci U S A , vol.84 , pp. 8483-8487
- May, W.S.¹ Sharkis, S.J.² Esa, A.H.³ Gebbia, V.⁴ Kraft, A.S.⁵ Pettit, R.G.⁶

4
- 0029892167
- The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: Dissociation of activities using 26-epi-bryostatin-1
- (1996) Cancer Res , vol.56 , pp. 2105-2111
- Szallasi, Z.¹ Du, L.² Levine, R.³ Lewin, N.E.⁴ Nguyen, P.N.⁵ Williams, M.D.⁶

5
- 0030807576
- Bryostatin 1: Differentiating agent from the depths
- (1997) Leuk Res , vol.21 , pp. 399-401
- Stone, R.M.¹

6
- 0030905835
- The antineoplastic agent bryostatin-1 induces proinflammatory cytokine production in human monocytes: Synergy with interleukin-2 and modulation of interleukin-2 R gamma chain expression
- (1997) Blood , vol.89 , pp. 3402-3411
- Bosco, M.C.¹ Roggschafer, S.² Taylor, L.S.³ Ortaldo, J.R.⁴ Longo, D.L.⁵ Espinoza-Delgado, I.⁶

7
- 0030134530
- Clinical trials referral resource: Clinical trials using bryostatin-1
- (1996) Oncology , vol.10 , pp. 740-742
- Pluda, J.M.¹ Cheson, B.D.² Phillips, P.H.³

8
- 0024536437
- Optimal two-stage designs for Phase II clinical trials
- (1989) Control Clin Trials , vol.10 , pp. 1-10
- Simon, R.¹

9
- 0030835841
- Spontaneous regression of metastatic renal cancer: Case report and literature review
- (1997) Am J Clin Oncol , vol.20 , pp. 416-418
- Edwards, M.J.¹ Anderson, J.A.² Angel, J.R.³ Harty, J.I.⁴

10
- 0027326957
- A Phase I study of intravenous bryostatin-1 in patients with advanced cancer
- (1993) Br J Cancer , vol.68 , pp. 418-444
- Prendiville, J.¹ Crowther, D.² Thatcher, N.³ Woll, P.J.⁴ Fox, B.W.⁵ McGown, A.⁶

11
- 0030712258
- Phase II trial of 5-fluorouracil, interferon-α and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma
- (1997) Cancer , vol.80 , pp. 2128-2132
- Ellerhorst, J.A.¹ Sella, A.² Amato, R.J.³ Tu, S.M.⁴ Millikan, R.E.⁵ Finn, L.D.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.